CN101612278B - Medicine for external application for treating pyogenic type contaminated wounds - Google Patents
Medicine for external application for treating pyogenic type contaminated wounds Download PDFInfo
- Publication number
- CN101612278B CN101612278B CN2008101502194A CN200810150219A CN101612278B CN 101612278 B CN101612278 B CN 101612278B CN 2008101502194 A CN2008101502194 A CN 2008101502194A CN 200810150219 A CN200810150219 A CN 200810150219A CN 101612278 B CN101612278 B CN 101612278B
- Authority
- CN
- China
- Prior art keywords
- medicine
- external application
- wounds
- pyogenic
- processed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a medicine for external application for treating pyogenic type contaminated wounds, which is characterized by comprising the following raw materials in the proportion by weight: 20-60 of catechu, 15-45 of dragon blood, 25-60 of prepared frankincense, 25-60 of prepared myrrh, 50-150 of calcined dragon bone, 60-200 of calcined gypsum, 20-60 of red halloysite, 40-80 of pearl, 0.5-1.0 of musk, 2-5 of borneol and 2-5 of calomel. The medicine for external application has the efficacies of diminishing inflammation and relieving pain, removing necrosis and promoting granulation, promoting discharge of venom, increasing the amount of blood supply, activating cell growth, accelerating growth of granulation tissue and promoting wounds to heal quickly. The medicine for external application is used for treating various pyogenic type contaminated wounds of dermis, fat, muscle, aponeurosis and periosteum. After clinical application for many years, the medicine for external application has good treating effect, and the healing rate reaches 90 percent. The course of treatment is generally ten days to two months, the healed wounds have unobvious scars, and patients have slight or no functional disorder.
Description
Technical field
The invention belongs to Chinese medicine, what be specifically related to is a kind of medicine for external use for the treatment of pyogenic type contaminated wounds.
Background technology
General shallow table contaminated wound has multiple medicine for external use to its treatment on the market, and particularly some Chinese herbal medicine have more curative effect preferably.But,, also can its external used medicine that curative effect is arranged normally be treated by surgical operation on the market up to now without any a kind of for serious pyogenic infection wound.Because contaminated wound is secondary healing, especially serious pyogenic infection wound is long by the time of surgical operation therapy, the expense height, and also more the back cicatrix is big, even have the local function obstacle.
Summary of the invention
The object of the present invention is to provide a kind of medicine for external use that can have good therapeutic effect to serious pyogenic infection wound.
The technical scheme that realizes above-mentioned purpose is: a kind of medicine for external use for the treatment of pyogenic type contaminated wounds, and press column weight amount proportion raw material and form:
Catechu 20～60 Sanguis Draxonis 15～45 Olibanum (processed)s 25～60
Myrrha (processed) 25～60 Os Draconis (calcined)s 50～150 Gypsum Fibrosum Preparatum 60～200
Halloysitum Rubrum 20～60 Margaritas 40～80 Moschus 0.5～1.0
Borneolum Syntheticum 2～5 Calomelass 2～5.
The preferred weight proportioning of above-mentioned raw materials is:
Catechu 40, Sanguis Draxonis 30, Olibanum (processed) 35, Myrrha (processed) 40, Os Draconis (calcined) 100, Gypsum Fibrosum Preparatum 150, Halloysitum Rubrum 45, Margarita 60, Moschus 0.8, Borneolum Syntheticum 3, Calomelas 4.
The compound method of medicine for external use is respectively above-mentioned all medicines to be ground into fine powder, and remix is mixed well and got final product.
Above-mentioned external prescription is separated:
Monarch drug: catechu, Sanguis Draxonis, Olibanum (processed), Myrrha (processed), reducing swelling and alleviating pain, removing dampness granulation promoting.
Ministerial drug: Os Draconis (calcined), Gypsum Fibrosum Preparatum, Halloysitum Rubrum, the removing dampness putrefaction removing helps the principal agent granulation promoting.
Adjuvant drug: Moschus, Margarita, blood circulation promoting, pain relieving reduces cicatrix, helps principal agent convergence granulation promoting.
Messenger drug: Calomelas, Borneolum Syntheticum, antibacterial anticorrosion antipruritic.
The usage of medicine for external use of the present invention is: earlier wound is handled by routine disinfection, infection face is fully exposed, be sprinkling upon on the wound surface with the amount of 0.1～0.3g medicated powder is even by every square centimeter of wound surface then, reuse dressing gets final product its wrapping, changes dressings once in one day.
The medicine for external use that the present invention treats pyogenic type contaminated wounds has that anti-inflammatory analgetic, putrefaction-removing granulation-promoting, promotion venom are discharged, improve amount of blood supply, enlivened the cell growth, the granulation tissue growth is fast, wound healing effect rapidly, is used for the treatment of the wound of various corium, fat, muscle, fascia, periosteum pyogenic infection.Through clinical use for many years, therapeutic effect is good, and cure rate reaches 90%, is generally the course of treatment ten days to two months, and cicatrix is not obvious behind the wound healing, dysfunction or light or nothing.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Embodiment 1:
Get catechu 20g, Sanguis Draxonis 20g, Olibanum (processed) 30g, Myrrha (processed) 35g, Os Draconis (calcined) 60g, Gypsum Fibrosum Preparatum 80g, Halloysitum Rubrum 30g, Margarita 50g, Moschus 0.8g, Borneolum Syntheticum 3g, Calomelas 3g.Described all medicines are ground into respectively to mix to mix well behind the fine powder get final product.
Embodiment 2:
Get catechu 40g, Sanguis Draxonis 30g, Olibanum (processed) 40g, Myrrha (processed) 40g, Os Draconis (calcined) 100g, Gypsum Fibrosum Preparatum 100g, Halloysitum Rubrum 30g, Margarita 50g, Moschus 0.8g, Borneolum Syntheticum 4g, Calomelas 3g.Described all medicines are ground into respectively to mix to mix well behind the fine powder get final product.
Embodiment 3:
Get catechu 55g, Sanguis Draxonis 40g, Olibanum (processed) 50g, Myrrha (processed) 50g, Os Draconis (calcined) 130g, Gypsum Fibrosum Preparatum 180g, Halloysitum Rubrum 50g, Margarita 80g, Moschus 1.0g, Borneolum Syntheticum 4.5g, Calomelas 5g.Described all medicines are ground into respectively to mix to mix well behind the fine powder get final product.
Claims (2)
1. a medicine for external use for the treatment of pyogenic type contaminated wounds is characterized in that, presses column weight amount proportion raw material and forms:
Catechu 20～60 Sanguis Draxonis 15～45 Olibanum (processed)s 25～60
Myrrha (processed) 25～60 Os Draconis (calcined)s 50～150 Gypsum Fibrosum Preparatum 60～200
Halloysitum Rubrum 20～60 Margaritas 40～80 Moschus 0.5～1.0
Borneolum Syntheticum 2～5 Calomelass 2～5.
2. according to the medicine for external use of the described treatment pyogenic type contaminated wounds of claim 1, it is characterized in that, press column weight amount proportion raw material and form:
Catechu 40, Sanguis Draxonis 30, Olibanum (processed) 35, Myrrha (processed) 40, Os Draconis (calcined) 100, Gypsum Fibrosum Preparatum 150, Halloysitum Rubrum 45, Margarita 60, Moschus 0.8, Borneolum Syntheticum 3, Calomelas 4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101502194A CN101612278B (en) | 2008-06-26 | 2008-06-26 | Medicine for external application for treating pyogenic type contaminated wounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101502194A CN101612278B (en) | 2008-06-26 | 2008-06-26 | Medicine for external application for treating pyogenic type contaminated wounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101612278A CN101612278A (en) | 2009-12-30 |
| CN101612278B true CN101612278B (en) | 2011-03-30 |
Family
ID=41492287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101502194A Expired - Fee Related CN101612278B (en) | 2008-06-26 | 2008-06-26 | Medicine for external application for treating pyogenic type contaminated wounds |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101612278B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102451321A (en) * | 2010-10-18 | 2012-05-16 | 黄昭世 | Plaster for treating skin trauma |
| CN102552614B (en) * | 2012-03-08 | 2013-09-18 | 张金国 | Traditional Chinese medicine powder for treating scald and preparation method thereof |
| CN102764353A (en) * | 2012-07-17 | 2012-11-07 | 王秋胜 | Externally applied paste for treating furunculous trauma infection |
| CN102813707B (en) * | 2012-08-02 | 2014-01-01 | 青岛绿曼生物工程有限公司 | Pure traditional Chinese medicine composition for treating pet abscess and preparation method thereof |
| CN103432320B (en) * | 2013-08-08 | 2015-09-16 | 张大星 | A kind of impel open wound and carbuncle skin ulcer swell ulceration healing external powder medicine for removing necrotic tissue and promoting muscle growing |
| CN108159220A (en) * | 2018-02-11 | 2018-06-15 | 宁夏张氏回医正骨医院 | A kind of time ointment for treating plant sore and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1158256A (en) * | 1996-02-29 | 1997-09-03 | 沈阳市骨科医院 | Pear skin growth powder |
| CN1686318A (en) * | 2005-03-29 | 2005-10-26 | 吴宝海 | Chinese medicinal composition for treating cervical vertebra disease, lumbar vertebra disease and ischialgia |
-
2008
- 2008-06-26 CN CN2008101502194A patent/CN101612278B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1158256A (en) * | 1996-02-29 | 1997-09-03 | 沈阳市骨科医院 | Pear skin growth powder |
| CN1686318A (en) * | 2005-03-29 | 2005-10-26 | 吴宝海 | Chinese medicinal composition for treating cervical vertebra disease, lumbar vertebra disease and ischialgia |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101612278A (en) | 2009-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101612278B (en) | Medicine for external application for treating pyogenic type contaminated wounds | |
| CN101066340B (en) | Compound externally applied tetrodotoxin ointment and its prepn | |
| CN101347559A (en) | Medicament for treating ulcer of skin | |
| CN101703651B (en) | Medicament for treating diabetic gangrene | |
| CN101306163A (en) | Zhixue shengji powder | |
| CN101049337B (en) | Medication for curing furuncle, sore, and carbuncle, and preparation method | |
| CN102283887B (en) | Ointment for treating burn | |
| CN1839898A (en) | Scar-free wet ointment for scald and burn and its preparation method | |
| CN100356936C (en) | Medicine oil for relaxing joints and its prepn | |
| CN1327828A (en) | Adhesive bandage able to relieve inflammation, astringe and grow muscle and its preparing process | |
| CN109674743B (en) | Wound care gel and preparation method thereof | |
| CN108392572B (en) | Plaster for removing stasis, promoting tissue regeneration, healing sore and relieving pain and preparation method and application thereof | |
| CN1444967A (en) | Chinese herbal medicine preparation for treating burns | |
| CN101564426B (en) | Medicament for external use for treating onychomycosis | |
| CN101259222B (en) | Medicaments for treating bone fracture bone fracture disease | |
| CN105560363A (en) | Traditional Chinese medicine external ointment for treating psoriasis and preparation method of traditional Chinese medicine external ointment | |
| CN102920858B (en) | External use medicine for treating dog skin bacterial infection ulcer | |
| CN1879725A (en) | Medicine for treating scald | |
| CN100562330C (en) | A kind of Chinese powder medicine of analgetic, hemostatic repercussive and sore-arresting functions and compound method thereof | |
| CN1275616C (en) | A pharmaceutical composition for treating burn and scald | |
| CN101884753A (en) | Medicament for treating empyrosis | |
| CN101032520A (en) | Traditional Chinese medicine powder for curing wound and scald | |
| CN107375704A (en) | A kind of Combined with Radiotherapy treats the Chinese medicine external powder of pernicious body surface ulcer | |
| CN116898932A (en) | External wound medicine and preparation method thereof | |
| CN105168510A (en) | Traditional Chinese medicinal preparation for treating trauma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110330 Termination date: 20140626 |
|
| EXPY | Termination of patent right or utility model |